VIEWPOINT THERAPEUTICS
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. The company's crystallin stabilizers include a small molecule that is active in preclinical models of age-related cataracts via a target-based screening and optimization effort, providing physicians with drugs to prevent or reverse protein misfolding, which is implicated in numerous common disorders of aging including cataracts, presbyopia, and neurodegenerative diseases.
VIEWPOINT THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.viewpointtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
39 M USD
Technology used in webpage:
SPF Invalid Certificate Dates Hawk Host Hawkhost DNS
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Novo Ventures
Novo Ventures investment in Series B - ViewPoint Therapeutics
Lagunita BioSciences
Lagunita BioSciences investment in Series B - ViewPoint Therapeutics
The Rise Fund
The Rise Fund investment in Series B - ViewPoint Therapeutics
Mission BioCapital
Mission BioCapital investment in Series B - ViewPoint Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - ViewPoint Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series B - ViewPoint Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series A - ViewPoint Therapeutics
Lagunita BioSciences
Lagunita BioSciences investment in Series A - ViewPoint Therapeutics
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series A - ViewPoint Therapeutics
Official Site Inspections
http://www.viewpointtherapeutics.com
- Host name: 172.67.129.21
- IP address: 172.67.129.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ViewPoint Therapeutics"
ViewPoint Therapeutics - Crunchbase Company Profile …
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. The company's crystallin stabilizers include a small molecule that is active in …See details»
ViewPoint Therapeutics - PitchBook
ViewPoint Therapeutics is headquartered in San Francisco, CA. What is the size of ViewPoint Therapeutics? ViewPoint Therapeutics has 11 total employees. What industry is ViewPoint …See details»
ViewPoint Therapeutics - VentureRadar
Visus Therapeutics is a clinical stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is developing …See details»
ViewPoint Therapeutics Inc - Company Profile and News
ViewPoint Therapeutics, Inc. operates as a biotechnology company. The Company develops treatments for diseases of protein misfolding, including cataracts. ViewPoint Therapeutics …See details»
ViewPoint Therapeutics - Products, Competitors, Financials, …
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. It is a developer of crystallin stabilizers …See details»
ViewPoint Therapeutics - Craft
See insights on ViewPoint Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ViewPoint Therapeutics - Company Profile - Tracxn
Oct 23, 2024 · ViewPoint Therapeutics has 9 institutional investors including Mission Bay Capital, The Rise Fund and Lagunita Biosciences. Ed Hurwitz is only Angel Investor in ViewPoint …See details»
ViewPoint Therapeutics | F6S
ViewPoint Therapeutics - ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, initially focused on cataracts.See details»
Viewpoint Therapeutics, Inc. - CAGE.report
Https://www.viewpointtherapeutics.com. Contact Person: George Jue County Code (3 digit): 075 Congressional District: 14 Metropolitan Statistical Area: 7360 CAGE Code: 76DQ3 ...See details»
ViewPoint Therapeutics Raises $4 Million in Series A
SAN FRANCISCO, May 05, 2016 (GLOBE NEWSWIRE) -- ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to …See details»
ViewPoint Therapeutics Raises $35 Million in Series B Financing
SAN FRANCISCO, Calif., March 5, 2018 – ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and …See details»
ViewPoint Appoints Dr. Robert Kim as Chief Medical Officer
SAN FRANCISCO, May 01, 2018 (GLOBE NEWSWIRE) -- ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to …See details»
ViewPoint Therapeutics CEO and Key Executive Team | Craft.co
ViewPoint Therapeutics's Director is Emmett Cunningham. Other executives include Ed Hurwitz, Chairman of Board of Directors; Leah Makley, President, Chief Executive Officer & Director …See details»
Working at ViewPoint Therapeutics - Glassdoor
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. I applied through a recruiter. I …See details»
ViewPoint Therapeutics - VentureRadar
Website: http://www.viewpointtherapeutics.com/ Develops treatments for protein misfolding diseases, including cataracts, aiming to revitalize vision loss treatment for presbyopia and …See details»
ViewPoint Therapeutics Raises $4 Million In Series A Financing
SAN FRANCISCO, May 05, 2016 (GLOBE NEWSWIRE) -- ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to …See details»
ViewPoint Therapeutics Raises $35M in Series B
VP1-001 is the first preclinical candidate from ViewPoint's discovery engine. For more information, please visit www.viewpointtherapeutics.com. About The Rise FundSee details»
ViewPoint Therapeutics Stock Price, Funding, Valuation, Revenue ...
Sep 28, 2022 · See ViewPoint Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on ViewPoint Therapeutics's post-money valuation and …See details»
ViewPoint Therapeutics gets $35M to advance non-surgical …
Mar 6, 2018 · With help from a socially conscious fund, San Francisco protein misfolding upstart ViewPoint Therapeutics has raised $35 million to take its eye drugs through proof-of-concept …See details»
What is ViewPoint Therapeutics? Company Culture, Mission, Values
Glassdoor gives you an inside look at what it's like to work at ViewPoint Therapeutics, including salaries, reviews, office photos and more. This is the ViewPoint Therapeutics company profile. …See details»